Enovis™ to Showcase Latest Innovations and Growing Foot & Ankle Portfolio at ACFAS 2023
08 févr. 2023 06h00 HE
|
Enovis Corporation
Wilmington, DE, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Today, Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced it will showcase its growing Foot & Ankle...
Enovis Expands Foot & Ankle Portfolio’s DynaClip® Family by Introducing Procedure-Specific Staples
17 janv. 2023 09h00 HE
|
Enovis Corporation
Wilmington, DE, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Today, Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced the launch of the DynaClip Delta™ and DynaClip...
Enovis Receives FDA Approval of Patient Specific Instrumentation for STAR® Ankle
01 déc. 2022 09h00 HE
|
Enovis Corporation
Wilmington, DE, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced that the U.S. Food and Drug Administration (FDA) has...
Enovis Introduces DynaNail Helix™ – a New Twist on Hindfoot Fusions
17 nov. 2022 08h00 HE
|
Enovis Corporation
Wilmington, DE, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announces the introduction of the DynaNail Helix™, the latest...
Enovis Announces Second Quarter 2022 Results
04 août 2022 06h00 HE
|
Enovis Corporation
Sales of $395 million include 11% reported growth, 3% organic growth and 5% sales-per-day growthReported operating income of $6 million, while adjusted EBITDA increased 11% to $56...
Enovis Announces Chief Financial Officer Transition Plan
30 juin 2022 08h00 HE
|
Enovis Corporation
Wilmington, DE, June 30, 2022 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced that Ben Berry, CFO of the Company’s...